PATHONOSTICS Trademark
Trademark Overview
On Wednesday, November 13, 2024, a trademark application was filed for PATHONOSTICS with the United States Patent and Trademark Office. The USPTO has given the PATHONOSTICS trademark a serial number of 98852418. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 13, 2024. This trademark is owned by PathoFinder Holding B.V.. The PATHONOSTICS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Diagnostic kits consisting primarily of reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, fungal diseases; Medical diagnostic reagents and assays for testing of body fluids; In vitro diagnostic preparations for medical purposes; Polymerase chain reaction (PCR) testing kits for scientific and medical research purposes.
Medical diagnostic equipment for testing for fungal diseases; Diagnostic kits for medical use, consisting primarily of buffers and reagents for use in detecting and determining fungal pathogens; Real-time Polymerase Chain Reaction (PCR) instruments for medical use; Polymerase chain reaction (PCR) testing kits for medical purposes, namely, for the diagnosis of fungal infections.
General Information
| Serial Number | 98852418 |
| Word Mark | PATHONOSTICS |
| Filing Date | Wednesday, November 13, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Wednesday, November 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Diagnostic kits consisting primarily of reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, fungal diseases; Medical diagnostic reagents and assays for testing of body fluids; In vitro diagnostic preparations for medical purposes; Polymerase chain reaction (PCR) testing kits for scientific and medical research purposes. |
| Goods and Services | Medical diagnostic equipment for testing for fungal diseases; Diagnostic kits for medical use, consisting primarily of buffers and reagents for use in detecting and determining fungal pathogens; Real-time Polymerase Chain Reaction (PCR) instruments for medical use; Polymerase chain reaction (PCR) testing kits for medical purposes, namely, for the diagnosis of fungal infections. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Sunday, November 30, 2014 |
| First Use In Commerce Date | Friday, March 26, 2021 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Sunday, November 30, 2014 |
| First Use In Commerce Date | Friday, March 26, 2021 |
Trademark Owner History
| Party Name | PathoFinder Holding B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Maastricht 6229EG
NL |
Trademark Events
| Event Date | Event Description |
| Wednesday, November 13, 2024 | NEW APPLICATION ENTERED |
